CODX vs DEO · rev $3.9M vs P/E 16, $55.86B cap
Co-Diagnostics, Inc. Common Stock (CODX) versus Diageo PLC ADR (DEO) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Diageo PLC ADR (DEO) is a beverages - wineries & distilleries company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
DEO does not have a complete income-statement cache yet.
CODX currently screens at market cap $31.4M. DEO currently screens at market cap $55.86B and trailing P/E 15.6.
Not investment advice. Open the CODX and DEO stock pages for the full models.
Not investment advice.